Today: 24 January 2026
Subscribe
Browse Category

SWX:ROG News 13 January 2026 - 18 January 2026

Roche stock in focus: Goldman flips to Neutral, UBS lifts target as Jan 29 results loom

Roche stock in focus: Goldman flips to Neutral, UBS lifts target as Jan 29 results loom

Zurich, Jan 18, 2026, 17:32 CET — Market closed Roche Holding Ltd’s non-voting shares ended Friday up 0.93%, closing at 348.90 Swiss francs. The stock has remained within a narrow band heading into Monday’s session. (MarketScreener) Goldman Sachs upgraded Roche from “sell” to “neutral” and boosted its 12-month price target to 365 Swiss francs, up from 260. The bank highlighted…
18 January 2026
·····
Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

NEW YORK, Jan 13, 2026, 12:18 EST — Regular session Shares of Structure Therapeutics climbed roughly 14% on Tuesday, adding to the stock’s recent swings. The move came as investors took a fresh look at the company’s newly announced patent licensing deal with Roche’s Genentech. (Reuters) This shift is significant as major drugmakers ramp up their push for obesity pills.…
13 January 2026
······

Stock Market Today

  • Dow and S&P 500 Face Volatile Week Amid Cooling U.S. Economic Growth
    January 23, 2026, 6:04 PM EST. The Dow and S&P 500 capped a volatile week marked by back-to-back weekly losses as U.S. economic data showed signs of cooling growth. S&P Global's preliminary Purchasing Managers' Index (PMI) readings for January revealed the manufacturing PMI at 51.9, below expectations but slightly up from December. The services PMI remained steady at 52.5. Overall, the Composite PMI edged up marginally to 52.8 but missed economists' forecasts. A PMI above 50 signals expansion, yet the pace has slowed since fall. Chris Williamson, Chief Business Economist at S&P Global, noted sustained growth but highlighted inflation pressures from tariffs driving up costs, sustaining business concerns over affordability and pricing.
Go toTop